Succinylcholine chloride - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for succinylcholine chloride and what is the scope of patent protection?

Succinylcholine chloride is the generic ingredient in five branded drugs marketed by Sandoz, Hospira, Accord Hlthcare, Adaptis, Amneal, Amphastar Pharms Inc, Amring Pharms, Aspiro, Baxter Hlthcare Corp, Be Pharms, Breckenridge, Deva Holding As, Dr Reddys, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Intl Medication, Mankind Pharma, Meitheal, Micro Labs, Nexus, Organon Usa Inc, Sagent Pharms Inc, Somerset Theraps Llc, Umedica, Zydus Pharms, Apothecon, and Steriscience, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for succinylcholine chloride. Thirty suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for succinylcholine chloride

US Patents:	0
Tradenames:	5
Applicants:	29
NDAs:	31
Drug Master File Entries:	5
Finished Product Suppliers / Packagers:	30
Raw Ingredient (Bulk) Api Vendors:	39
Clinical Trials:	2
Patent Applications:	2,291
Drug Prices:	Drug price trends for succinylcholine chloride
What excipients (inactive ingredients) are in succinylcholine chloride?	succinylcholine chloride excipients list
DailyMed Link:	succinylcholine chloride at DailyMed

See drug prices for succinylcholine chloride

Recent Clinical Trials for succinylcholine chloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Rutgers, The State University of New Jersey	N/A
Avera Pharmaceuticals	Phase 1/Phase 2

See all succinylcholine chloride clinical trials

Generic filers with tentative approvals for SUCCINYLCHOLINE CHLORIDE

Applicant	Application No.	Strength	Dosage Form
⤷ Sign Up	⤷ Sign Up	100MG/5ML (20MG/ML)	SOLUTION;INTRAMUSCULAR, INTRAVENOUS

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for succinylcholine chloride

Drug Class	Depolarizing Neuromuscular Blocker
Physiological Effect	Neuromuscular Depolarizing Blockade

Medical Subject Heading (MeSH) Categories for succinylcholine chloride

Neuromuscular Depolarizing Agents

US Patents and Regulatory Information for succinylcholine chloride

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Adaptis	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	INJECTABLE;INJECTION	214308-001	May 22, 2020	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Accord Hlthcare	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	INJECTABLE;INJECTION	213705-001	May 20, 2020		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hospira	QUELICIN PRESERVATIVE FREE	succinylcholine chloride	INJECTABLE;INJECTION	008845-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hospira	QUELICIN PRESERVATIVE FREE	succinylcholine chloride	INJECTABLE;INJECTION	008845-004	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sandoz	ANECTINE	succinylcholine chloride	INJECTABLE;INJECTION	008453-002	Approved Prior to Jan 1, 1982	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Dr Reddys	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	INJECTABLE;INJECTION	210698-001	Aug 2, 2019	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Gland Pharma Ltd	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	INJECTABLE;INJECTION	214246-001	Jun 16, 2020	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.